Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome
Authors:
- Aaron L. CarrelACAaron L. Carrel
- Barbara Y. WhitmanBWBarbara Y. Whitman
- David B. AllenDADavid B. Allen
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 137 (1) , 42-49
Abstract
No abstract availableKeywords
Funding Information
- Genentech
This publication has 19 references indexed in Scilit:
- Assessment of SNRPN expression as a molecular tool in the diagnosis of Prader-Willi syndromeMolecular Diagnosis, 1999
- Growth hormone treatment of children with Prader‐Willi syndrome affects linear growth and body composition favourablyActa Paediatrica, 1998
- Age- and maturity-related changes in body composition during adolescence into adulthood: The Fels Longitudinal StudyInternational Journal of Obesity, 1997
- Growth Hormone Secretion and Effects of Growth Hormone Therapy on Growth Velocity and Weight Gain in Children with Prader-Willi SyndromeJournal of Pediatric Endocrinology and Metabolism, 1996
- Influence of metabolic substrates and obesity on growth hormone secretionTrends in Endocrinology & Metabolism, 1995
- Growth Hormone Secretion in Prader‐Willi SyndromeActa Paediatrica, 1990
- Genetic imprinting suggested by maternal heterodisomy in non-deletion Prader-Willi syndromeNature, 1989
- Impaired Growth Hormone Responses to Growth Hormone–Releasing Factor in ObesityNew England Journal of Medicine, 1984
- The Prader-Willi SyndromeMedicine, 1983
- Deletions of Chromosome 15 as a Cause of the Prader–Willi SyndromeNew England Journal of Medicine, 1981